Total assets decreased 24.3%
Total assets changed -24.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$7.8M→$5.9M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →RKDA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current assets decreased 24.3%
Current assets changed -24.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$7.6M→$5.7M4 prior comparisons
Stock-based compensation decreased 83.7%
Stock-based compensation changed -83.7% from the comparable as-filed period.
$86,000→$14,0003 prior comparisons
Inventory / revenue moved 3789 bp lower
Inventory / revenue changed -3789 basis points from the comparable as-filed period.
102.34%→64.45%3 prior comparisons
Working capital / assets moved 425 bp lower
Working capital / assets changed -425 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
73.70%→69.46%4 prior comparisons
Operating cash-flow margin moved 11762 bp higher
Operating cash-flow margin changed +11762 basis points from the comparable as-filed period.
-139.73%→-22.11%3 prior comparisons
Gross margin moved 36 bp higher
Gross margin changed +36 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
43.37%→43.73%3 prior comparisons
Operating margin moved 6 bp higher
Operating margin changed +6 basis points from the comparable as-filed period.
-34.43%→-34.37%3 prior comparisons
Current liabilities decreased 10.5%
Current liabilities changed -10.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.8M→$1.6M4 prior comparisons
Revenue decreased 0.8%
Revenue changed -0.8% from the comparable as-filed period.
$1.5M→$1.4M3 prior comparisons
Operating income increased 1.0%
Operating income changed +1.0% from the comparable as-filed period.
-$501,000→-$496,0003 prior comparisons
R&D / revenue moved 62 bp lower
R&D / revenue changed -62 basis points from the comparable as-filed period.
0.62%→0.00%3 prior comparisons
Cost of revenue decreased 1.5%
Cost of revenue changed -1.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$824,000→$812,0003 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.